Latest News about Biotech
Recent news which mentions Biotech
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
November 14, 2024
From Benzinga
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug
November 14, 2024
From Benzinga
FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
November 14, 2024
From Benzinga
Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial
November 14, 2024
From Benzinga
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
November 14, 2024
From Benzinga
EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder
November 14, 2024
From Benzinga
Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels
November 14, 2024
From Benzinga
Amazon's Secret Fertility Tracker Project Launched Under Jeff Bezos Reportedly Halted Amid CEO Andy Jassy's Cost-Cutting Drive
November 14, 2024
From Benzinga
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
November 13, 2024
From Benzinga
BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition
November 13, 2024
From Benzinga
Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis
November 13, 2024
From Benzinga
Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
November 13, 2024
From Benzinga
BioRestorative Therapies Lower Back Candidate Shows Decrease In Pain, Increased Function
November 13, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free